Chemicals found in shells used to manufacture shell oil have been linked to cancerous growths in mice, according to a new study.

The findings, published today in the journal Nature, could have implications for developing new therapies to treat cancers that have not yet been identified.

A number of different compounds found in shellfish, including the common chrysotile, are often used to coat the shell.

In some cases, these compounds have been used to prepare shell oil.

However, researchers found that when they used compounds from the chrysotean shell, these chemical reactions turned the cells into cancerous tumors.

The chrysotes shells contain more than 2,000 chemical compounds, and researchers thought that this number could be higher.

So they tried to make chrysots shell oil using chrysotos shell extract.

The researchers found it worked, and that chrysotics shell oil could inhibit cancer.

The scientists believe that this compound could be a new way to treat cancer, since it was found in other shells, but the method for testing it was not clear.

They also tested different combinations of chrysos shell extract with other compounds to see which could inhibit growth of cancer cells.

In some cases they found that chryotos shell oil inhibited growth of some cancers, but it did not affect others.

Chrysotiles shell extract was also tested against two other cancer cells: the liver and prostate, and it was able to stop both cells from forming tumors.

The shell extract also stopped some types of cancer cell growth, but not others.

“Chrysoteans shell extract is effective against some types, but does not affect other types,” the researchers wrote in the study.

“This is important because some cancers may be more aggressive and resistant to chrysotoan extract than others,” they wrote.

For instance, some cancers are resistant to other compounds found on the shell, such as the one found in chrysotic extract.

“Our findings indicate that chyrosotile shell extract may be a promising treatment for cancers that are resistant or resistant to any of the compounds found naturally in the shell,” the study concluded.

“These findings will likely help to inform the development of new treatments to treat the disease,” said senior author Dr. Erika Paz, a professor of molecular medicine at the University of Texas Health Science Center at Houston.

The results are also encouraging for people with cancers who are resistant and resistant and do not respond to other treatments, such a stem cell therapy, or a chemotherapy treatment.

“If we can develop new drugs that target these cells and not just the cancer cells, we may be able to prevent them from growing and metastasizing,” she said.

Paz is one of two co-authors on the study, which was conducted by researchers at the Max Planck Institute for Cancer Research and the University Hospital of Tuebingen.

Other co-author is Dr. David A. Kohn of the Max-Planck Institute, and other co-researchers include scientists from the National Institute of Health.

Follow me on Twitter @maria_le_gala.

Read or Share this story: